Baloxavirmarboxil
Baloxavirmarboxil
Klass : A
Visa all info
Skriv ut
Kontakta oss
EPAR Xofluza. EMA [www]. [updated 2022-08-01, cited 2023-01-11].
Retout S, De Buck S, Jolivet S, Duval V, Cosson V. Pharmacokinetics-Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or B. Clin Pharmacol Ther. 2022;112(2):372-381.
Nezu K, Hayashida S, Nagano N, Udagawa S, Morioka I. Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir. Medicina (Kaunas). 2023;59(9):.
Fujiwara N, Fujiwara T, Ise Y. Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan. J Pharm Health Care Sci. 2023;9(1):3.
GUPS. Stockholm: Region Stockholm. 2022 [cited 2023-06-20.]
- EPAR Xofluza. EMA [www]. [updated 2022-08-01, cited 2023-01-11].
- Retout S, De Buck S, Jolivet S, Duval V, Cosson V. Pharmacokinetics-Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or B. Clin Pharmacol Ther. 2022;112(2):372-381.
- Nezu K, Hayashida S, Nagano N, Udagawa S, Morioka I. Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir. Medicina (Kaunas). 2023;59(9):.
- Fujiwara N, Fujiwara T, Ise Y. Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan. J Pharm Health Care Sci. 2023;9(1):3.
- GUPS. Stockholm: Region Stockholm. 2022 [cited 2023-06-20.]